Sign in

CIK 0000949858 · Non-accelerated filer<br>Smaller reporting company

ACHIEVE LIFE SCIENCES, INC.

Sign in to watch
Ticker
ACHV
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
954343413
Phone
425-686-1500
Business address
22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
Former names
ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC
  1. EFFECT Other Notice of Effectiveness
  2. S-1MEF Other S-1MEF
  3. S-1/A Offering Registration Statement
  4. CORRESP Other Correspondence Between Filers and SEC Staff
  5. CORRESP Other Correspondence Between Filers and SEC Staff
  6. S-1/A Offering Registration Statement
  7. FWP Offering Free Writing Prospectus
  8. S-1/A Offering Registration Statement
  9. CT ORDER Other Confidential Order
  10. 8-K Event Executive or director change · Bylaws or fiscal year change · Shareholder vote results · Other events
  11. 10-Q/A Report 10-Q/A
  12. S-1 Offering Registration Statement
  13. 10-Q Report Quarterly Report
  14. 8-K Event Results of operations
  15. DEF 14A Proxy Proxy Statement
  16. PRE 14A Proxy Proxy Statement (Preliminary)
  17. 10-K Report Annual Report
  18. 8-K Event Results of operations
  19. 8-K Event Regulation FD disclosure
  20. 8-K Event Material agreement · Director nominations · Regulation FD disclosure

Page 27 of 68 · 1,358 filings